Author, Subjects, Keywords

Cited Author

 
 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Molecular Factors in Human Implantation: Adhesion Molecules, Proteases and Cytokines

Lim, K.J.H., (2003) Molecular Factors in Human Implantation: Adhesion Molecules, Proteases and Cytokines. Malaysian Journal of Pathology, 25 (1). pp. 1-13. ISSN 0126-8635

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
147Kb

Official URL: http://www.mjpath.org.my/past_issue/MJP2003.1/Review(Molecular)01.pdf

Affiliations

University Putra Malaysia, Dept. of Human Growth and Development

Abstract

Successful human reproduction remains an enigma, but this is slowly changing in the current era of expanding scientific knowledge. The discovery of various molecular factors such as adhesion molecules, proteases and cytokines have in recent years been at the forefront of medical research. The growing importance of immunology in particular has led to novel new immuno-modulatory therapies and increasing research into this new aspect of reproductive immunology may well prove to be the most important breakthrough in understanding the fundamentals of human reproduction. Implantation represents the first step in the complex interactions and processes involved in foetalmaternal interaction, which continues throughout pregnancy gestation and culminates in the birth of an infant. It is therefore vital that we understand the myriad processes controlling implantation in order to build a firm foundation for exploring reproductive immunology research in the new millennium. This review brings together and presents an overview of the potential roles of currently known molecular factors such as adhesion molecules, proteases, cytokines and its interaction with the maternal immune response, incorporating the findings of previous published research performed by the author on cytokines and reproductive immunology.

Item Type:Journal
Keywords:immuno-modulatory therapies
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:3851

1. Bergh PA, Navot D. The impact of embryonic development and endometrial maturity on the timing of implantation. Fertil Steril 1992; 58: 537-42.

41. Sutherland AE, Calarco PG, Damsky CH. Developmental regulation of integrin expression at the time of implantation in the mouse embryo. Development 1993: 119: 1175-86.

42. Dedhar S. Regulation of expression of the cell adhesion receptors, integrins, by recombinant human interleukin-1β in human osteosarcoma cells: Inhibition of cell proliferation and stimulation of alkaline phophatase activity. J Cell Physiol 1989;138: 291-99.

43. Ignotz RA, Heino J, Massague J. Regulation of cell adhesion receptors by transforming growth factor: Regulation of vitronectin receptor and LFA-1. J Biol Chem 1989; 264: 389-92.

44. Arcecei RJ, Shanahan F, Stanley ER. et al. The temporal expression and location of colony stimulating factor-1 (CSF-1) and the receptor in the female reproductive tract are consistent with CSF- 1 regulated placental development. Proc Natl Acad Sci USA 1989; 86: 8818-22.

45. Pollard JW, Hunt JS, Wiktor-Jedrzejczak W. et al. A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility. Dev Biol 1991; 148: 273-83.

46. Daiter E, Pampfer S, Teung YG. et al. Expression of colony stimulating factor-1 (CSF-1) in the human uterus and placenta. J Clin Endocrin Metab 1992;74: 850-8.

47. Bhatt H, Brunet LJ, Stewart CL. Uterine expression of leukaemia inhibitory factor coincides with the onset of blastocyst implantation. Proc Natl Acad Sci USA1991; 88: 11408-12.

48. Stewart C.L, Kaspar P, Brunet LJ, et al. Blastocyst implantation depends on maternal expression ofleukaemia inhibitory factor. Nature 1992; 359: 76-9.

49. Charnock-Jones D, Sharkey A, Fenwick P. et al. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. J Reprod Fertil 1994; 101:421-6.

50. Kojima K, Kanzaki H, Iwai M. et al. Expression of leukaemia inhibitory factor in human endometrium and placenta. Biol Reprod 1994; 50: 882-7.

51. Arici A, Engin O, Attar E. et al. Modulation of leukaemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrin Metab 1995; 80: 1908-15.

52. De M, Sanford TR, Wood GW. Expression of interleukin-1, interleukin-6 and tumour necrosis factor alpha in mouse uterus during the periimplantation period of pregnancy. J Reprod Fertil 1993; 97: 83-9.

53. Choudhuri R, Wood GW. Production of interleukin- 1, interleukin-6 and tumour necrosis factor alpha in the uterus of pseudopregnant mice. Biol Reprod 1993; 49: 596-603.

54. Zolti M, Ben-Rafael Z, Meirom R. et al. Cytokines involvement in oocytes and early embryos. Fertil Steril 1991; 56: 265-72.

55. Simon C, Frances A, Piquette GN. et al. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist (IL-1Ra). Endocrinology 1994; 134: 521-8.

56. Kauma S, Matt D, Strom S. et al. Interleukin 1 beta, human leukocyte antigen HLA-DR alpha and transforming growth factor beta expression in endometrium, placenta and placental membranes. Am J Obstet Gynecol 1990; 163: 1430-7.

57. Simon C, Piquette GN, Frances A. et al. Localisation of interleukin-1 type receptor and interleukin-1 beta in human endometrium throughout the menstrual cycle. J Clin Endocrin Metab 1993; 77:549-55.

58. Simon C, Piquette GN, Frances A. et al. Interleukin-1 type receptor messenger ribonucleic acid (mRNA) expression in human endometrium throughout the menstrual cycle. Fertil Steril 1993; 59: 791-6.

59. Simon C, Frances A, Yon Lee B. et al. Immunohistochemical localization, identification and regulation of the interleukin-1 receptor antagonist in the human endometrium. Mol HumReprod 1995; 1, see Hum Reprod 10: 2472-7.

60. Tarlatzis BC, Bili H, Daniilidis M. et al. Interleukin production by human pre-implantation embryos Fertil Steril 1994; 63 (suppl): O-165.

61. Austgulen R, Arntzen KJ, Vatten LJ. et al. () Detection of cytokines (interleukin-1, interleukin- 6, transforming growth factor-beta) and soluble tumour necrosis factor receptors in embryo culture fluids during in-vitro fertilization. Hum Reprod 1995;10:171-6.

62. Hardy RI, Anderson DJ, Hill JA. Lack of correlation between IL-1 alpha in pre-implantation culture media and pregnancy outcome Fertil Steril 1993;61 (suppl): 0-139.

63. Seifer DB, Romero R, Berlinsky D, et al. Absence of immunoreactive cytokines in supernatants of individual pre-implantation human embryos. Am J Reprod Immunol (Copenhagen) 1993; 30:105-7.

64. De los Santos MJ, Mercader A, Frances A. et al.Immunoreactive human embryonic interleukin-1 system and endometrial factors regulating their secretion during embryonic development. Biol Reprod 1996; 54: 563-74.

65. Bischof P. Blastocyst implantation from the physiology to the experimental model. In: Yoshinaga K, Rao AJ and Adiga PR (Eds) Perspectives in Primate Reproductive Biology. New Delhi, India:Wiley Eastern Ltd; 1991. pp62-76.

66. Puistola U, Ronnberg L, Martikainen H, Turpeenniemi-Hujanen T. The human embryo produces basement membrane collagen (type IV collagen) degrading protease activity. Hum Reprod 1989: 4: 309-11.

67. Emonard HP, Christiane Y, Smet M, Grimaud JA, Foidart JM. Type IV and interstitial collagenolytic activities in normal and malignant trophoblast cells are specifically regulated by the extracellular matrix. Invas Metastas 1990; 10:170-77.

68. Alexander CM, Werb Z. Extracellular matrix degradation. In: Hay ED (Eds) Cell Biology of Extracellular Matrix, New York: Plenum Press: 1991. pp255-302.

69. Strickland S, Reich E, Sherman MI. Plasminogen activator in early embryogenesis: Enzyme production by trophoblast and parietal endoderm. Cell 1976; 9: 231-40.

70. Sappino AP, Huarte J, Belin D. et al. Plasminogen activators in tissue remodelling and invasion: mRNA localization in mouse ovaries and implanting embryos. J Cell Biol 1989; 109: 2471-9.

71. Queenan JT, Kao LC, Arboleda CE. et al. Regulation of urokinase type plasminogen activator production by cultured human cytotrophoblast. J Biol Chem 1987; 262: 10903-6.

72. Emmeis JJ, Kooistra T. IL-1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 1986; 163: 11260.

73. Lockwood CJ, Krikun G, Papp C. et al. the role of progestationally regulated stromal cell tissue factor and type 1 plasminogen activator inhibitor (PAI-1) in endometrial haemostasis and menstruation. Ann NY Acad Sci 1994; 734: 57-79.

74. Graham CH, Lysiak JJ, McCrae KR. et al. Location of transforming growth factor beta at the human fetal-maternal interface: Role in trophoblast growth and differentiation. Biol Reprod 1992; 46: 561-72.

75. Janeway CA. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992; 13: 11-16.

76. Rinkevich B. Immunology of human implantation: from the invertebrate’s point of view. Hum Reprod 1998; 13: 455-9.

77. Romagnani S. Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 1992; 98: 279-85.

78. Romagnani S. Biology of human TH 1 and TH 2 cells. J Clin Immunol 1995; 15:121-9.

79. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternalfetal relationship: Is successful pregnancy a TH 2 phenomenon? Immunol Today 1993; 14: 353-356.

80. Tabibzadeh S, Sun XZ. Cytokine expression in human endometrium throughout the menstrual cycle. Hum Reprod 1992; 7: 1214-21.

81. Bulmer J. In: Kurpisz and Fernandez (Eds), Immunology of Human Reproduction. UK: Bios Scientific Publishing; 1995. pp313-34.

82. Klentzeris LD, Bulmer JN, Warren MA, Morrison L, Li TC, Cooke ID. Endometrial lymphoid tissue in the timed endometrial biopsy: Morphometric and immunohistochemical aspects. Am J Obstet Gynecol 1992; 167: 667-74.

83. Lim KJH, Odukoya OA, Li TC, Cooke ID. (). Cytokines and immuno-endocrine factors in recurrent miscarriage. Hum Reprod Update 1996:2: 469-81.

84. Hill JA. T helper 1 type immunity to trophoblast: Evidence for a new immunological mechanism for recurrent abortion in women. Hum Reprod 1995: 10 Supp 2: 114-20.

85. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S. Defective production of both leukaemia inhibitory factor and type 2 T helper cytokines by decidual T cells in unexplained recurrent abortions. Nature Med 1998; 4: 1020-4.

86. Lim KJH, Odukoya OA, Ajjan R, Li TC, Weetman AP, Cooke ID. The profile of cytokine mRNA expression in peri-implantation human endometrium. Mol Hum Reprod 1998:4:77-81.

87. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O’Garra A, Murphy KM. Development of TH1 CD4+ T cells through IL-12 produced by Listeriainduced macrophages. Science 1993: 260: 547-9.

88. Seder RA, Paul WE, Davis MM, Fazekas de St G.F. The presence of IL-4 during in vitro priming determines the lymphokine producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med 1992; 176: 1091-8.

89. Piccotti JR, Chan SY, Goodman RE, Magram J, Eichwald EJ, Bishop DK. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. J Immunol 1996; 157: 1951-7.

90. Punnonen J, Aversa G, Cocks B.G. et al. Interleukin 13 induces interleukin 4 independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993; 90: 3730-34.

91. Neppert J, Mueller-Eckhardt G, Neumeyer H, et al. Pregnancy maintaining antibodies: Workshop report. (Giessen 1988 ) J Reprod Immunol 1989; 15: 159-67.

92. Coulam CB. Immunologic tests in the evaluation of reproductive disorders: A critical review. Am J Obstet Gynecol 1992; 167: 1844-51.

93. Lim KJH, Odukoya OA, Ajjan R, Li TC, Weetman AP, Cooke ID. Role of T helper cytokines in human reproduction Fertil Steril 2000; 73: 136-142.

94. Piccinni MP, Giudizi MG, Biagiotti R, et al. Progesterone favors the development of human T helper cells producing TH-2 type cytokines and promotes both IL-4 production and membrane CD30 expression in established TH-1 cell clones. J Immunol 1995; 155: 128-33.

95. Turnbull AC, Patten PT, Flint APF, Keirse MJNC, Jeremy JY, Anderson ABM. Significant fall in progesterone and rise in oestradiol levels in human peripheral plasma before the onset of labour. Lancet 1974; i: 101-4.

96. Wilcox AJ, Weinberg CR, O’Connor JF, et al. Incidence of early loss of pregnancy. N Engl J Med 1988; 319: 189-94.

97. Ellish NJ, Saboda K, O’Connor J, Nasca PC, Stanek EJ, Boyle C. A prospective study of early pregnancy loss. Hum Reprod 1996; 11: 406-12.

98. Edwards RG. Clinical approaches to increasing uterine receptivity during human implantation. Hum Reprod 1995; 10 Suppl 2: 60-6.

99. Bentin-Ley U, Pedersen B, Lindenberg S, Larsen JF, Hamberger L, Horn T. Isolation and culture of human endometrial cells in a three-dimensional culture system. J Reprod Fertil 1994; 101: 327-32.

100. Bentin-Ley U, Lindenberg S, Horn T, Larsen JF. Ultrastructure of endometrial epithelial cells in a three-dimensional culture system for human implantation studies. J Assist Reprod Genet 1995;

12: 632-8.

101. Charnock-Jones DS, Sharkey AM, Jaggers DC, Yoo HJ, Heap RB, Smith SK. In-vivo gene transfer to the uterine endometrium, Hum Reprod 1997; 12:17-20.

102. Chaouat G, Menu E, Clark DA, Dy M, Minkowski M, Wegmann TG. Control of fetal survival in CBA/ JxDBA/2 mice by lymphokine therapy. J Reprod Fertil 1990: 89: 447-58.

103. Chaouat G, Menu E, Assal-Meliani A, et al. Allopregnancy is a TH 2 like phenomenon: IL 10 can prevent CBAxDBA/2 fetal wastage and TH 2 cytokine can be induced in vivo by tau interferons. Colloque Foundation Marcel Merieux, Annecy. 1994.

Repository Staff Only: item control page
 
 
 
 
 
 
© Copyright 2007 MyAIS Faculty of Computer Science and Information Technology, University of Malaya – All Rights Reserved. Malaysian Abstracting and Indexing System is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.